This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Digweed, M. Articles by Sperling, K. Search for Related Content PubMed PubMed Citation Articles by Digweed, M. Articles by Sperling, K.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 01 1995, 305-314, Vol 15, No. 1
Copyright © 1995, American Society for Microbiology

Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene

M Digweed, U Gunthert, R Schneider, H Seyschab, R Friedl and K Sperling
Institute of Human Genetics, Free University of Berlin, Germany.

Primary fibroblasts from patients with the genetic disease Fanconi anemia, which are hypersensitive to cross-linking agents, were used to screen a cDNA library for sequences involved in their abnormal cellular response to a cross-linking challenge. By using library partition and microinjection of in vitro-transcribed RNA, a cDNA clone, pSPHAR (S- phase response), which is able to correct the permanent repression of semiconservative DNA synthesis rates characteristic of these cells, was isolated. Wild-type SPHAR mRNA is expressed in all fibroblasts so far analyzed, including those of Fanconi anemia patients. Correction of the abnormal response in these cells appears therefore to be due to overexpression after cDNA transfer rather than to genetic complementation. The cDNA contains an open reading frame coding for a polypeptide of 7.5 kDa. Rabbit antiserum directed against a SPHAR peptide detects a protein of 7.9 kDa in Western blots (immunoblots) of whole-cell extracts from proliferating, but not resting, fibroblasts. The deduced amino acid sequence of SPHAR contains a motif found in the cyclins, and it is proposed that SPHAR acts within the injected cell by interfering with the cyclin-controlled maintenance of S phase. In agreement with this proposal, normal cells transfected with an antisense SPHAR expression vector have a significantly reduced rate of DNA synthesis during S phase and a prolonged G2 phase, reflecting the need for postreplicative DNA processing before entry into mitosis.

This article has been cited by other articles:

• Toll-Riera, M., Bosch, N., Bellora, N., Castelo, R., Armengol, L., Estivill, X., Mar Alba, M. (2009). Origin of Primate Orphan Genes: A Comparative Genomics Approach. Mol Biol Evol 26: 603-612 [Abstract] [Full Text]  
• Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J. P., Kajigaya, S., Sloand, E. M., Young, N. S. (2004). Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 104: 4210-4218 [Abstract] [Full Text]  
• Heinrich, M. C., Hoatlin, M. E., Zigler, A. J., Silvey, K. V., Bakke, A. C., Keeble, W. W., Zhi, Y., Reifsteck, C. A., Grompe, M., Brown, M. G., Ellen Magenis, R., Olson, S. B., Bagby Jr, G. C. (1998). DNA Cross-Linker-Induced G2/M Arrest in Group C Fanconi Anemia Lymphoblasts Reflects Normal Checkpoint Function. Blood 91: 275-287 [Abstract] [Full Text]  
• Kupfer, G. M., Yamashita, T., Naf, D., Suliman, A., Asano, S., D'Andrea, A. D. (1997). The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2. Blood 90: 1047-1054 [Abstract] [Full Text]